Analysed LB PHARMACEUTICALS INC (LBRX:NASDAQ) News Sources
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11-08-2026
yahoo.com
LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment
06-10-2026
yahoo.com
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
09-10-2026
yahoo.com
LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress
10-10-2026
yahoo.com
What is the current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ) is $39.7.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is $-0.45.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is -1.1208%.
What is the most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is .
SEC-8K** Filing Available For LB PHARMACEUTICALS INC (LBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.